These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9658137)

  • 1. Circumvention of immunity to the adenovirus major coat protein hexon.
    Roy S; Shirley PS; McClelland A; Kaleko M
    J Virol; 1998 Aug; 72(8):6875-9. PubMed ID: 9658137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.
    Bradley RR; Maxfield LF; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
    J Virol; 2012 Jan; 86(2):1267-72. PubMed ID: 22072746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
    Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
    J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.
    Bruder JT; Chen P; Semenova E; Thomas CA; Konovalova S; Ekberg G; Ettyreddy D; McVey D; Gall JG; King CR; Brough DE
    J Virol; 2013 Sep; 87(17):9661-71. PubMed ID: 23824800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
    Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
    J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexon gene switch strategy for the generation of chimeric recombinant adenovirus.
    Youil R; Toner TJ; Su Q; Chen M; Tang A; Bett AJ; Casimiro D
    Hum Gene Ther; 2002 Jan; 13(2):311-20. PubMed ID: 11812286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon.
    Rux JJ; Burnett RM
    Mol Ther; 2000 Jan; 1(1):18-30. PubMed ID: 10933908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
    Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
    Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
    Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
    PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A; Harvey BG; Yao J; Wolff G; Kovesdi I; Crystal RG; Falck-Pedersen E
    Hum Gene Ther; 1996 Jan; 7(1):79-87. PubMed ID: 8825871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods.
    Rux JJ; Kuser PR; Burnett RM
    J Virol; 2003 Sep; 77(17):9553-66. PubMed ID: 12915569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
    Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
    J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.
    Gahéry-Ségard H; Farace F; Godfrin D; Gaston J; Lengagne R; Tursz T; Boulanger P; Guillet JG
    J Virol; 1998 Mar; 72(3):2388-97. PubMed ID: 9499099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
    Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
    Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic strategy to decrease complement activation with adenoviral therapies.
    Gentile CM; Borovjagin AV; Richter JR; Jani AH; Wu H; Zinn KR; Warram JM
    PLoS One; 2019; 14(4):e0215226. PubMed ID: 31026285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenovirus type 40 hexon: sequence, predicted structure and relationship to other adenovirus hexons.
    Toogood CI; Murali R; Burnett RM; Hay RT
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3203-14. PubMed ID: 2481711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.
    Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH
    Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.
    Wu H; Dmitriev I; Kashentseva E; Seki T; Wang M; Curiel DT
    J Virol; 2002 Dec; 76(24):12775-82. PubMed ID: 12438602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues.
    Crawford-Miksza L; Schnurr DP
    J Virol; 1996 Mar; 70(3):1836-44. PubMed ID: 8627708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.